Stock listing
Milan:1ABBV AbbVie Inc. Azioni
Italian listing (Milan) of AbbVie Inc. · home listing NYSE:ABBV
Follow AbbVie Inc. into a list and get an email when it puts out news.
Home listing price · NYSE:ABBV
$289.12 USD +6.44 (+2.3%)
Delayed at least 15 minutes · 2:44 PM EDT, Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:ABBV
- Day range so far
- $285.00 – $290.98 USDDelayed at least 15 minutes · 2:44 PM EDT, Oct 20, 2026
- Volume
- 2.77M sharesDelayed at least 15 minutes · 2:44 PM EDT, Oct 20, 2026
- Market cap
- $510.9B USDDelayed at least 15 minutes · 2:44 PM EDT, Oct 20, 2026 · price × 1.77B shares outstanding
- 52-week range
- $190.75 – $291.40 USDLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:ABBV · Home | $289.12 USD | +6.44 (+2.3%) | 2,767,497 | $286.90 | $290.98 | $285.00 | $282.68 | Delayed 15+ min · 2:44 PM EDT, Oct 20, 2026 |
| TSX:ABBV | $39.34 CAD | -0.28 (-0.7%) | 9,378 | $39.56 | $39.75 | $39.31 | $39.62 | Close on Oct 19, 2026 |
| Xetra:4AB | €252.80 EUR | -0.30 (-0.1%) | 666 | €253.30 | €255.80 | €252.40 | €253.10 | Close on Oct 19, 2026 |
| Cboe Canada:ABBV | $39.32 CAD | -0.33 (-0.8%) | 1,200 | $39.35 | $39.40 | $39.32 | $39.65 | Close on Oct 19, 2026 |
| B3:ABBV34 | 89.68 BRL | -0.58 (-0.6%) | 177 | 88.45 | 90.15 | 88.45 | 90.26 | Close on Oct 19, 2026 |
| BMV:ABBV | $5,244.00 MXN | -33.50 (-0.6%) | 144 | $5,244.00 | $5,244.00 | $5,244.00 | $5,277.50 | Close on Oct 19, 2026 |
| Frankfurt:4AB | €254.10 EUR | -0.70 (-0.3%) | 30 | €253.30 | €256.30 | €253.30 | €254.80 | Close on Oct 19, 2026 |
| Stuttgart:4AB | €252.40 EUR | -1.40 (-0.6%) | 1 | €253.80 | €254.80 | €252.10 | €253.80 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NYSE:ABBV · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $282.68 | -2.74 | -1.0% | $284.23 | $287.93 | $282.59 | 3,986,797 | |
| $285.42 | +2.02 | +0.7% | $283.61 | $286.64 | $282.96 | 5,776,793 | |
| $283.40 | -0.08 | 0.0% | $288.28 | $291.40 | $282.81 | 7,621,730 | |
| $283.48 | +9.12 | +3.3% | $277.00 | $285.40 | $275.97 | 5,633,169 | |
| $274.36 | -6.76 | -2.4% | $283.29 | $283.43 | $273.70 | 6,408,500 | |
| $281.12 | +4.65 | +1.7% | $277.65 | $281.30 | $276.01 | 5,593,700 | |
| $276.47 | +4.05 | +1.5% | $271.53 | $277.60 | $270.38 | 4,297,946 | |
| $272.42 | +1.06 | +0.4% | $270.98 | $272.52 | $265.71 | 5,494,940 | |
| $271.36 | +4.67 | +1.8% | $268.40 | $274.94 | $266.89 | 6,079,078 | |
| $266.69 | +0.93 | +0.3% | $267.74 | $268.86 | $260.62 | 4,501,087 | |
| $265.76 | +2.94 | +1.1% | $261.27 | $267.34 | $260.29 | 7,544,505 | |
| $262.82 | +2.89 | +1.1% | $259.74 | $264.06 | $257.87 | 5,863,068 | |
| $259.93 | -1.66 | -0.6% | $260.51 | $262.32 | $259.00 | 3,892,076 | |
| $261.59 | -1.70 | -0.6% | $264.60 | $265.36 | $261.59 | 4,389,160 | |
| $263.29 | -2.99 | -1.1% | $265.45 | $268.93 | $261.52 | 4,004,368 | |
| $266.28 | +1.94 | +0.7% | $264.33 | $267.74 | $263.38 | 4,429,512 | |
| $264.34 | -0.78 | -0.3% | $265.49 | $266.00 | $262.59 | 2,541,718 | |
| $265.12 | +0.04 | 0.0% | $265.37 | $267.41 | $263.09 | 3,458,166 | |
| $265.08 | -0.13 | 0.0% | $266.00 | $269.39 | $263.59 | 3,469,242 | |
| $265.21 | +0.73 | +0.3% | $263.10 | $266.82 | $262.15 | 2,766,286 | |
| $264.48 | +0.52 | +0.2% | $263.07 | $266.60 | $261.23 | 3,438,150 | |
| $263.96 | -0.06 | 0.0% | $263.29 | $266.34 | $262.44 | 8,176,607 | |
| $264.02 | +1.51 | +0.6% | $262.61 | $264.62 | $260.88 | 3,509,941 | |
| $262.51 | -0.53 | -0.2% | $261.99 | $264.00 | $260.98 | 3,118,268 | |
| $263.04 | +1.27 | +0.5% | $260.00 | $264.81 | $257.80 | 5,120,219 | |
| $261.77 | +4.65 | +1.8% | $261.67 | $264.65 | $260.10 | 4,512,420 | |
| $257.12 | +2.12 | +0.8% | $253.92 | $259.61 | $253.92 | 4,308,856 | |
| $255.00 | +4.09 | +1.6% | $251.23 | $255.31 | $249.74 | 4,397,653 | |
| $250.91 | +2.13 | +0.9% | $247.73 | $251.18 | $246.77 | 3,866,951 | |
| $248.78 | -7.68 | -3.0% | $251.84 | $254.62 | $248.41 | 5,572,102 | |
| $256.46 | -3.75 | -1.4% | $257.96 | $258.91 | $255.58 | 4,729,800 | |
| $260.21 | -1.51 | -0.6% | $264.00 | $264.25 | $257.14 | 2,878,739 | |
| $261.72 | +1.73 | +0.7% | $262.70 | $262.97 | $257.70 | 4,225,524 | |
| $259.99 | +3.57 | +1.4% | $260.99 | $262.27 | $257.79 | 3,866,739 | |
| $256.42 | +0.94 | +0.4% | $254.17 | $258.24 | $252.33 | 4,315,487 | |
| $255.48 | -2.67 | -1.0% | $258.67 | $259.00 | $255.08 | 3,224,862 | |
| $258.15 | -4.75 | -1.8% | $260.81 | $262.50 | $257.25 | 4,764,797 | |
| $262.90 | -2.89 | -1.1% | $264.60 | $265.00 | $260.31 | 3,308,871 | |
| $265.79 | +1.27 | +0.5% | $264.50 | $266.91 | $263.03 | 3,671,623 | |
| $264.52 | -0.44 | -0.2% | $263.99 | $266.04 | $262.07 | 3,883,803 | |
| $264.96 | +3.13 | +1.2% | $260.70 | $266.84 | $260.10 | 5,157,192 | |
| $261.83 | -4.14 | -1.6% | $265.69 | $265.93 | $260.48 | 5,228,907 | |
| $265.97 | +7.05 | +2.7% | $261.51 | $266.97 | $259.55 | 5,535,972 | |
| $258.92 | +8.59 | +3.4% | $253.93 | $259.18 | $252.41 | 5,010,229 | |
| $250.33 | +0.87 | +0.3% | $249.49 | $251.49 | $248.31 | 4,648,771 | |
| $249.46 | -1.36 | -0.5% | $250.60 | $250.61 | $247.68 | 4,195,386 | |
| $250.82 | +2.06 | +0.8% | $252.94 | $255.30 | $249.35 | 4,370,406 | |
| $248.76 | -1.33 | -0.5% | $245.98 | $250.09 | $245.52 | 3,780,452 | |
| $250.09 | +2.12 | +0.9% | $248.14 | $250.77 | $247.18 | 4,485,470 | |
| $247.97 | +1.93 | +0.8% | $245.65 | $248.01 | $244.03 | 4,209,941 | |
| $246.04 | +2.17 | +0.9% | $243.62 | $246.76 | $241.95 | 4,930,711 | |
| $243.87 | -2.33 | -0.9% | $249.04 | $249.95 | $241.20 | 4,570,167 | |
| $246.20 | +2.40 | +1.0% | $247.00 | $249.38 | $243.76 | 5,193,732 | |
| $243.80 | -1.30 | -0.5% | $246.74 | $246.91 | $242.39 | 8,028,831 | |
| $245.10 | -5.84 | -2.3% | $251.45 | $256.20 | $244.44 | 7,435,935 | |
| $250.94 | -6.47 | -2.5% | $252.54 | $255.52 | $247.00 | 7,258,176 | |
| $257.41 | -5.89 | -2.2% | $258.38 | $259.89 | $253.51 | 6,406,625 | |
| $263.30 | +0.10 | 0.0% | $264.21 | $267.47 | $262.76 | 5,563,736 | |
| $263.20 | +6.29 | +2.4% | $262.83 | $266.92 | $261.45 | 7,060,442 | |
| $256.91 | -2.45 | -0.9% | $259.00 | $262.10 | $256.78 | 5,404,809 | |
| $259.36 | +2.44 | +0.9% | $258.54 | $260.22 | $256.77 | 4,195,437 | |
| $256.92 | +3.62 | +1.4% | $253.98 | $258.38 | $253.10 | 4,623,010 | |
| $253.30 | -2.80 | -1.1% | $257.81 | $257.81 | $252.25 | 4,953,191 | |
| $256.10 | +2.72 | +1.1% | $253.70 | $257.06 | $252.60 | 4,819,291 | |
| $253.38 | -1.11 | -0.4% | $253.10 | $256.15 | $252.68 | 4,332,803 |
- Ticker
- Milan:1ABBV
- Asset type
- Stock
- Exchange
- Milan
- Currency
- EUR
What changed lately
Latest news release · Oct 20, 2026
Health Canada Approves SKYRIZI® (risankizumab) for Children Living with Moderate to Severe Plaque Psoriasis
Latest earnings call · Jul 31, 2026
AbbVie (NYSE:ABBV) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Jun 22, 2026
Merger or Acquisition (June 2026)
Merger or acquisition · 15 slides
Calls
Upcoming
AbbVie (NYSE:ABBV) Q3 2026 Earnings Call
Fri, Oct 30, 2026 · 9:00 AM ET
Register
Replays
AbbVie (NYSE:ABBV) Q2 2026 Earnings Call
Fri, Jul 31, 2026 · 9:00 AM ET
Watch TranscriptAbbVie (NYSE:ABBV) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 9:00 AM ET
Watch TranscriptAbbVie (NYSE:ABBV) Q4 2025 Earnings Call
Wed, Feb 04, 2026 · 9:00 AM ET
Watch Transcript
Latest news
AbbVie Presents Data for ABBV-466, a Novel Dual-Targeting Therapy Demonstrating Higher Endoscopic Remission Rates Than Either Anti-IL-23 or Anti-α4β7 Monotherapy in Moderate to Severe Crohn's Disease
Oct 19, 2026
Closed $282.68 (-1.0%) on Oct 19, 2026
Correction: AbbVie
Oct 18, 2026
Closed $282.68 (-1.0%) on Oct 19, 2026
AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio
Oct 18, 2026
Closed $282.68 (-1.0%) on Oct 19, 2026
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
Oct 17, 2026
Closed $282.68 (-1.0%) on Oct 19, 2026
AbbVie Presents New Phase 3 AFFIRM Data Showing Clinical and Endoscopic Outcomes With Subcutaneous SKYRIZI® (risankizumab-rzaa) in Patients With Moderately to Severely Active Crohn's Disease
Oct 13, 2026
Closed $274.36 (-2.4%) on Oct 13, 2026
New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease
Oct 11, 2026
Closed $281.12 (+1.7%) on Oct 12, 2026
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
Oct 5, 2026
Closed $265.76 (+1.1%) on Oct 5, 2026
AbbVie Presents Long-Term RINVOQ® (upadacitinib) Data Showing Continued Repigmentation in Non-Segmental Vitiligo
Oct 1, 2026
Closed $259.93 (-0.6%) on Oct 1, 2026
Decks
Merger or Acquisition (June 2026)
Merger or acquisition · 15 slides · Jun 22, 2026
Q4 2025 Earnings Presentation
Earnings · 4 slides · Feb 4, 2026
Q1 2025 Earnings Presentation
Earnings · 9 slides · Apr 25, 2025
Fact Sheet (2025)
Fact sheet · 6 slides · 2025
AbbVie Inc. on 6ix
- News releases
- 140 in the last 12 months · 180 in all · newest Oct 20, 2026 · oldest 2025
- Calls
- 31 calls with a replay · 31 with a transcript · latest Jul 31, 2026
- Decks
- 21 decks · latest Jun 22, 2026
Where AbbVie Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:ABBV · Home listing | NYSE | United States | USD |
| gettex:4AB | gettex | Germany | EUR |
| BCBA:ABBV | BCBA | Argentina | ARS |
| SET:ABBV19 | SET | Thailand | THB |
| Tradegate:4AB | Tradegate | Germany | EUR |
| TSX:ABBV | TSX | Canada | CAD |
| Xetra:4AB | Xetra | Germany | EUR |
| Cboe Canada:ABBV | Cboe Canada | Canada | CAD |
| B3:ABBV34 | B3 | Brazil | BRL |
| SET:ABBV80 | SET | Thailand | THB |
| LS Exchange:A1J84E | LS Exchange | Germany | EUR |
| BMV:ABBV | BMV | Mexico | MXN |
| Milan:1ABBV · This page | Milan | Italy | EUR |
| BCBA:ABBVD | BCBA | Argentina | USD |
| LSIN:0QCV | LSIN | United Kingdom | USD |
| EUROTLX:4ABBV | EUROTLX | Italy | EUR |
| Frankfurt:4AB | Frankfurt | Germany | EUR |
| Lang & Schwarz:A1J84E | Lang & Schwarz | Germany | EUR |
| SIX Swiss:ABBV | SIX Swiss | Switzerland | CHF |
| Stuttgart:4AB | Stuttgart | Germany | EUR |
| BIVA:ABBV | BIVA | Mexico | MXN |
| BCBA:ABBVC | BCBA | Argentina | USD |
| BOATS:ABBV | BOATS | United States | USD |
| VIE:ABBV | Vienna | Austria | EUR |
| Munich:4AB | Munich | Germany | EUR |
| BCS:ABBV | BCS | Chile | USD |
| Dusseldorf:4AB | Dusseldorf | Germany | EUR |
| BX Swiss:4AB | BX Swiss | Switzerland | CHF |
| Hamburg:4AB | Hamburg | Germany | EUR |
| BSESOF:4AB | BSESOF | Bulgaria | EUR |
| Dusseldorf:4AB0 | Dusseldorf | Germany | EUR |
| Frankfurt:4AB0 | Frankfurt | Germany | EUR |
| SIX Swiss:ABBV.USD | SIX Swiss | Switzerland | USD |
| BCS:ABBVCL | BCS | Chile | CLP |
| Turquoise:4ABD | Turquoise | United Kingdom | EUR |
| BCBA:ABBV.CI | BCBA | Argentina | ARS |
| Hanover:4AB | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about AbbVie Inc.